{"news_desk": "OpEd", "print_page": "23", "subsection_name": null, "section_name": "Opinion", "byline": {"original": "By MATT JABLOW", "person": [{"firstname": "Matt", "rank": 1, "lastname": "JABLOW", "organization": "", "role": "reported"}]}, "abstract": "Op-Ed article by Matt Jablow of insurance company Evergreen Health calls for misleading television advertisements touting benefits of Pharmaceuticals to be pulled from air; cites Bristol-Myers Squibb ad for immunotherapy drug Opdivo for lung cancer patients, noting drug performed poorly in clinical trials.", "type_of_material": "Op-Ed", "word_count": "776", "keywords": [{"rank": "1", "value": "Lung Cancer", "is_major": "Y", "name": "subject"}, {"rank": "2", "value": "Clinical Trials", "is_major": "N", "name": "subject"}, {"rank": "3", "value": "Advertising and Marketing", "is_major": "Y", "name": "subject"}, {"rank": "4", "value": "Bristol Myers Squibb Company", "is_major": "Y", "name": "organizations"}, {"rank": "5", "value": "Food and Drug Administration", "is_major": "N", "name": "organizations"}, {"rank": "6", "value": "Drugs (Pharmaceuticals)", "is_major": "Y", "name": "subject"}], "lead_paragraph": "Opdivo didn\u2019t help my wife, or almost anyone else. So why can Bristol-Myers Squibb market it on TV?", "pub_date": "2016-08-09T04:00:00+0000", "document_type": "article", "source": "The New York Times", "snippet": "Opdivo didn\u2019t help my wife, or almost anyone else. So why can Bristol-Myers Squibb market it on TV?...", "multimedia": [{"height": 126, "subtype": "wide", "legacy": {"widewidth": "190", "wide": "images/2016/08/09/opinion/09JABLOW-web/09JABLOW-web-thumbWide.jpg", "wideheight": "126"}, "type": "image", "width": 190, "url": "images/2016/08/09/opinion/09JABLOW-web/09JABLOW-web-thumbWide.jpg"}, {"height": 432, "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "432", "xlarge": "images/2016/08/09/opinion/09JABLOW-web/09JABLOW-web-articleLarge.jpg"}, "type": "image", "width": 600, "url": "images/2016/08/09/opinion/09JABLOW-web/09JABLOW-web-articleLarge.jpg"}, {"height": 75, "subtype": "thumbnail", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/08/09/opinion/09JABLOW-web/09JABLOW-web-thumbStandard-v2.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "url": "images/2016/08/09/opinion/09JABLOW-web/09JABLOW-web-thumbStandard-v2.jpg"}], "web_url": "http://www.nytimes.com/2016/08/09/opinion/cancer-drug-ads-vs-cancer-drug-reality.html", "slideshow_credits": null, "blog": [], "_id": "57aa4d5a95d0e021d797f79c", "headline": {"main": "Cancer-Drug Ads vs. Cancer-Drug Reality", "content_kicker": "Op-Ed Contributor", "print_headline": "Drug Ads vs. Drug Reality", "kicker": "Op-Ed Contributor"}}